METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGS
Open Access
- 15 September 2003
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 31 (10), 1269-1277
- https://doi.org/10.1124/dmd.31.10.1269
Abstract
The pharmacokinetics and metabolism of the l-threo isoleucine thiazolidide dipeptidyl peptidase IV inhibitor, di-[2S,3S]-2-amino-3-methyl-pentanoic-1,3-thiazolidine fumarate (ILT-threo) and its allo stereoisomer (ILT-allo) were evaluated in rats, dogs, and monkeys. Both compounds were well absorbed (>80%) in all species, and most of the dose (>60%) was recovered in urine. Metabolites identified in all species included a sulfoxide (M1), a sulfone (M2), and a carbamoyl glucuronide (M3). For both compounds, parent drug had moderate systemic clearance in rats and dogs (∼20–35 ml/min/kg in both species) and lower clearance in monkeys (∼6–9 ml/min/kg). In rats, M1 was present in systemic circulation in concentrations similar to that of parent drug, whereas in dogs and monkeys, exposures to M1 were higher than for parent drug. In dogs, exposures to the sulfoxide metabolite were ∼2 to 3 times higher after administration of ILT-allo than after administration of ILT-threo. Carbamoyl glucuronidation was an important biotransformation pathway in dogs. Circulating levels of M3 were significant in the dog, and present only in trace levels in rats and monkeys. M3 could be produced in in vitro systems in a NaHCO3 buffer under a CO2-saturated atmosphere and in the presence of UDP-glucuronic acid and alamethicin.Keywords
This publication has 26 references indexed in Scilit:
- Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact PeptideJournal of Clinical Endocrinology & Metabolism, 2000
- Glucagon-Like Peptide-1-(7-36)Amide Is Transformed to Glucagon-Like Peptide-1-(9-36)Amide by Dipeptidyl Peptidase IV in the Capillaries Supplying the L Cells of the Porcine IntestineEndocrinology, 1999
- Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker ratsDiabetologia, 1999
- Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazoneBritish Journal of Clinical Pharmacology, 1999
- Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cellsEndocrinology, 1992
- On the formation of carbamate glucuronidesXenobiotica, 1990
- Formation of N-carboxy compounds during trimethylsilanization of amino acids in the presence of carbon dioxideJournal of Chromatography A, 1987
- Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.Proceedings of the National Academy of Sciences, 1987
- Species Differences in the Urinary Excretion of the Novel Primary Amine Conjugate: Tocainide Carbamoyl O-β-D-GlucuronideJournal of Pharmaceutical Sciences, 1982
- Tocainide Conjugation in Humans: Novel Biotransformation Pathway for a Primary AmineJournal of Pharmaceutical Sciences, 1980